Is Tirzepatide Prescription Only in the UK?

Why tirzepatide carries a prescription-only classification

Tirzepatide (sold in the UK as Mounjaro) is a dual GIP and GLP-1 receptor agonist, the only medicine in its class currently licensed for weight management in this country. Its prescription-only status is not a bureaucratic formality. The medicine acts on hormone receptors involved in appetite regulation and blood-sugar control, which means it has meaningful interactions with other conditions and treatments. A prescriber's assessment catches contraindications that a self-reported order form would miss: a history of pancreatitis, certain thyroid conditions, or concurrent medicines that affect absorption all affect whether tirzepatide is appropriate for a given person.

NICE's appraisal of tirzepatide (published as TA1026 in December 2024) reinforces this by recommending it specifically within a framework of clinical oversight, with a review point if less than five percent of body weight is lost after six months at the highest tolerated dose. The NICE recommendation exists alongside, not instead of, the POM classification; both apply whether the prescription comes through the NHS or a private route.

In the SURMOUNT-1 trial (2,539 adults, 72 weeks), participants on the highest dose saw average body-weight reductions of around 20–21%. Results at that level are only meaningful when the person is genuinely suitable for the medicine and supported throughout. That suitability check is what a prescription represents.

What the law permits, and what it rules out

Under the Human Medicines Regulations 2012, a Prescription-Only Medicine may only be supplied against a prescription written by an authorised prescriber: a doctor, a dentist, or a registered Independent Prescriber such as a pharmacist prescriber. No prescription means no lawful supply, full stop. This applies to every channel: high-street pharmacies, online pharmacies registered with the GPhC, and private clinics alike.

The legal prescription requirement does not, however, mean you must see a GP in person. A GPhC-registered online pharmacy staffed by Independent Prescribers can conduct a clinical consultation remotely, issue a prescription, and dispense the medicine. What cannot happen lawfully is supply without that prescribing step occurring at all. When you see tirzepatide advertised on social media without any mention of a consultation or prescription, that is the clearest possible red flag, and our guide on where you can safely buy Mounjaro explains exactly which channels are legitimate and which to avoid. The MHRA has taken enforcement action against unlicensed sellers and, in October 2025, raided the first UK site found to be producing counterfeit tirzepatide pens. You can verify whether an online pharmacy is GPhC-registered at the GPhC register before placing any order.

For more detail on Mounjaro's prescription status specifically, including what a valid private prescription covers, that page sets out the practical steps clearly.

Who meets the licensed eligibility criteria

The UK licence for tirzepatide covers adults aged 18 and over with a BMI of 30 or above, or a BMI of 27 or above when at least one weight-related condition is present, conditions such as hypertension, high cholesterol, obstructive sleep apnoea, type 2 diabetes, or cardiovascular disease. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, reflecting differences in metabolic risk at equivalent BMI values.

Meeting the BMI threshold is a starting point, not a guarantee. A prescriber considers the whole picture: current medications, relevant medical history, and whether the expected benefit outweighs any individual risk. If you are unsure about the rules around whether tirzepatide requires a prescription and what that process involves, that page answers the most common questions clearly. Tirzepatide is not recommended during pregnancy, while breastfeeding, or for anyone who is trying to conceive. It is not licensed for use in people under 18. Certain conditions (including a personal or family history of medullary thyroid carcinoma or a rare syndrome called MEN2) are contraindications that a prescriber must screen for.

If you want to understand what obtaining a private tirzepatide prescription actually involves, that page covers the consultation process in detail. And if you are comparing routes (NHS vs private, timing, costs) our weight-loss treatment overview lays out the landscape without jargon.

Getting a lawful prescription: the route through a regulated online pharmacy

For most people researching tirzepatide privately, the practical route is a consultation with a GPhC-registered online pharmacy whose prescribers review the case and, if appropriate, issue the prescription and dispense the medicine from the same regulated facility. This is entirely lawful and, done properly, safe.

At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not automated software) on the day it arrives. Identity is verified with photo ID, and weight is confirmed on a live video call, which is a level of clinical governance that many providers do not require. If you order before noon on a weekday (something worth knowing if payday falls on a Monday and you are ready to start), treatment dispatched that day arrives with DPD the next working morning, tracked, in plain packaging.

You can read more about how buying Mounjaro online works through a regulated pharmacy, including what the consultation covers and what happens after your prescription is approved. For broader context on what tirzepatide is and how it works, our Mounjaro overview is the right place to start. When you are ready to check your eligibility and speak to a prescriber, the next step is a free consultation with our clinical team.